Antibodies

17 Apr 2007 Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
17 Apr 2007 Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
13 Apr 2007 Genmab Initiates HuMax-EGFr Combination Study in Non Small Cell Lung Cancer
13 Apr 2007 XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
07 Apr 2007 FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients
05 Apr 2007 Merck KGaA: Erbitux Meets Primary Endpoint in First-Line Phase III Head and Neck Cancer Study
05 Apr 2007 Merck KGaA: Erbitux Meets Primary Endpoint in First-Line Phase III Head and Neck Cancer Study
05 Apr 2007 Genzyme Files for Expanded Label for Campath(R) as First-Line Treatment for B-CLL Patients
05 Apr 2007 Crucell Announces Start of Rabies Phase I Antibody Cocktail Clinical Study in India four months after launching initial US Trial
05 Apr 2007 AVEO enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO's Novel Anti-HGF Antibody
05 Apr 2007 Cerimon Pharmaceuticals Initiates ARREST UC-1, a Global Phase 2b Study of Basiliximab in Patients with Steroid-Refractory Ulcerative Colitis
04 Apr 2007 WILEX gives positive update of current pivotal Phase III trial of RENCAREX(R)
04 Apr 2007 Viventia Biotech initiates patient treatment for Vicinium(TM) Phase II bladder cancer trial
04 Apr 2007 Pharmexa and Affitech enter into an exclusive license agreement to promote Diabody technology
03 Apr 2007 Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
31 Mar 2007 Astellas Licenses Regeneron Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
30 Mar 2007 NEOPHARM Reports on FDA Meeting
30 Mar 2007 Anthrax Monoclonal Antibody Valortim(TM) Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection
30 Mar 2007 XTL Announces the Completion of Phase I Study with XTL-6865 in Patients with Chronic Hepatitis C
29 Mar 2007 MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's Third Japanese Pharmaceutical Alliance
29 Mar 2007 Avastin Approved in Europe for First Line Treatment of Women with Metastatic Breast Cance
28 Mar 2007 Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
28 Mar 2007 Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
27 Mar 2007 Herceptin receives positive opinion in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2- and hormone receptor-positive metastatic breast cancer
27 Mar 2007 European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R)

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top